The Clinical Value of Nutritional Care before and during Active Cancer Treatment

by Aprile, Giuseppe, Basile, Debora, Giaretta, Renato, Schiavo, Gessica, La Verde, Nicla, Corradi, Ettore, Monge, Taira, Agustoni, Francesco, Stragliotto, Silvia
Published in Nutrients (2021)

What Medical Oncologist Residents Think about the Italian Speciality Schools: A Survey of the Italian Association of Medical Oncology (AIOM) on Educational, Clinical and Research A...

by Moretti, Anna, Ghidini, Michele, De Angelis, Carmine, Lambertini, Matteo, Cremolini, Chiara, Imbimbo, Martina, Berardi, Rossana, Di Maio, Massimo, Cascinu, Stefano, La Verde, Nicla
Published in PLoS One (2016)

A proposal of a “ready to use” COVID-19 control strategy in an Oncology ward: Utopia or reality?

by Dalu, Davide, Rota, Selene, Cona, Maria Silvia, Brambilla, Anna Maria, Ferrario, Sabrina, Gambaro, Anna, Meroni, Luca, Merli, Stefania, Farina, Gabriella, La Verde, Nicla
Published in Crit Rev Oncol Hematol (2021)

Role of patient and tumor characteristics in sentinel lymph node metastasis in patients with luminal early breast cancer: an observational study

by La Verde, Nicla, Biagioli, Elena, Gerardi, Chiara, Cordovana, Andrea, Casiraghi, Chiara, Floriani, Irene, Bernardin, Elena, Farina, Gabriella, Di Cosimo, Serena, Dazzani, Maria Chiara, Gherardi, Giorgio
Published in Springerplus (2016)

The prognostic role of tumor size in early breast cancer in the era of molecular biology

by Kasangian, Anaid Anna, Gherardi, Giorgio, Biagioli, Elena, Torri, Valter, Moretti, Anna, Bernardin, Elena, Cordovana, Andrea, Farina, Gabriella, Bramati, Annalisa, Piva, Sheila, Dazzani, Maria Chiara, Paternò, Emanuela, La Verde, Nicla Maria
Published in PLoS One (2017)

Prospective observational study on the impact of the 21-gene assay on treatment decisions and resources optimization in breast cancer patients in Lombardy: The BONDX study

by Zambelli, Alberto, Simoncini, Edda, Giordano, Monica, La Verde, Nicla, Farina, Gabriella, Torri, Valter, Colombo, Giorgio, Piacentini, Giulia, Fotia, Vittoria, Vassalli, Lucia, Pugliese, Palma, Poletti, Paola, Caremoli, Elena Rota, Tondini, Carlo
Published in Breast (2020)

Randomised Phase II Trial (NCT00637975) Evaluating Activity and Toxicity of Two Different Escalating Strategies for Pregabalin and Oxycodone Combination Therapy for Neuropathic Pai...

by Garassino, Marina Chiara, Piva, Sheila, La Verde, Nicla, Spagnoletti, Ilaria, Iorno, Vittorio, Carbone, Claudia, Febbraro, Antonio, Bianchi, Anna, Bramati, Annalisa, Moretti, Anna, Ganzinelli, Monica, Marabese, Mirko, Gentili, Marta, Torri, Valter, Farina, Gabriella
Published 2013

Eribulin in pretreated metastatic breast cancer patients: results of the TROTTER trial—a multicenter retrospective study of eribulin in real life

by Garrone, Ornella, Montemurro, Filippo, Saggia, Chiara, La Verde, Nicla, Vandone, Anna Maria, Airoldi, Mario, De Conciliis, Enrico, Donadio, Michela, Lucio, Francesco, Polimeni, Maria Antonia, Oletti, Maria Vittoria, Giacobino, Alice, Merlano, Marco Carlo
Published in Springerplus (2016)

Tumor-Educated Platelets and Angiogenesis in Glioblastoma: Another Brick in the Wall for Novel Prognostic and Targetable Biomarkers, Changing the Vision from a Localized Tumor to a...

by Campanella, Rolando, Guarnaccia, Laura, Cordiglieri, Chiara, Trombetta, Elena, Caroli, Manuela, Carrabba, Giorgio, La Verde, Nicla, Rampini, Paolo, Gaudino, Chiara, Costa, Antonella, Luzzi, Sabino, Mantovani, Giovanna, Locatelli, Marco, Riboni, Laura, Navone, Stefania Elena, Marfia, Giovanni
Published in Cells (2020)

Receptor Activator of NF-kB (RANK) Expression in Primary Tumors Associates with Bone Metastasis Occurrence in Breast Cancer Patients

by Santini, Daniele, Schiavon, Gaia, Vincenzi, Bruno, Gaeta, Laura, Pantano, Francesco, Russo, Antonio, Ortega, Cinzia, Porta, Camillo, Galluzzo, Sara, Armento, Grazia, La Verde, Nicla, Caroti, Cinzia, Treilleux, Isabelle, Ruggiero, Alessandro, Perrone, Giuseppe, Addeo, Raffaele, Clezardin, Philippe, Muda, Andrea Onetti, Tonini, Giuseppe
Published 2011

Neoadjuvant eribulin mesylate following anthracycline and taxane in triple negative breast cancer: Results from the HOPE study

by Di Cosimo, Serena, La Verde, Nicla, Moretti, Anna, Cazzaniga, Marina Elena, Generali, Daniele, Bianchi, Giulia Valeria, Mariani, Luigi, Torri, Valter, Crippa, Flavio, Paolini, Biagio, Scaperrotta, Gianfranco, De Santis, Maria Carmen, Di Nicola, Massimo, Apolone, Giovanni, Gulino, Alessandro, Tripodo, Claudio, Colombo, Mario Paolo, Folli, Secondo, de Braud, Filippo
Published in PLoS One (2019)

BRCA1/2 Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic Laboratories

by Capoluongo, Ettore, La Verde, Nicla, Barberis, Massimo, Bella, Maria Angela, Buttitta, Fiamma, Carrera, Paola, Colombo, Nicoletta, Cortesi, Laura, Genuardi, Maurizio, Gion, Massimo, Guarneri, Valentina, Lorusso, Domenica, Marchetti, Antonio, Marchetti, Paolo, Normanno, Nicola, Pasini, Barbara, Pensabene, Matilde, Pignata, Sandro, Radice, Paolo, Ricevuto, Enrico, Sapino, Anna, Tagliaferri, Pierosandro, Tassone, Pierfrancesco, Trevisiol, Chiara, Truini, Mauro, Varesco, Liliana, Russo, Antonio, Gori, Stefania
Published in Diagnostics (Basel) (2019)

Efficacy and safety of T-DM1 in the ‘common-practice’ of HER2+ advanced breast cancer setting: a multicenter study

by Fabi, Alessandra, De Laurentiis, Michelino, Caruso, Michele, Valle, Enrichetta, Moscetti, Luca, Santini, Daniele, Cannita, Katia, Carbognin, Luisa, Ciccarese, Mariangela, Rossello, Rosalba, Arpino, Grazia, Leonardi, Vita, Montemurro, Filippo, La Verde, Nicla, Generali, Daniele, Zambelli, Alberto, Scandurra, Giuseppa, Russillo, Michelangelo, Paris, Ida, D'Ottavio, Anna Maria, Filippelli, Gianfranco, Giampaglia, Marianna, Stani, Simonetta, Fabbri, Agnese, Alesini, Daniele, Cianniello, Daniela, Giannarelli, Diana, Cognetti, Francesco
Published in Oncotarget (2017)

NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2(+) breast cancer

by Jacobs, Samuel A., Robidoux, André, Abraham, Jame, Pérez-Garcia, José Manuel, La Verde, Nicla, Orcutt, James M., Cazzaniga, Marina E., Piette, Fanny, Antolín, Silvia, Aguirre, Elena, Cortes, Javier, Llombart-Cussac, Antonio, Di Cosimo, Serena, Kim, Rim S., Feng, Huichen, Lipchik, Corey, Lucas, Peter C., Srinivasan, Ashok, Wang, Ying, Song, Nan, Gavin, Patrick G., Balousek, April D., Paik, Soonmyung, Allegra, Carmen J., Wolmark, Norman, Pogue-Geile, Katherine L.
Published in Breast Cancer Res (2019)

Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ br...

by Jacobs, Samuel A., Robidoux, André, Abraham, Jame, Pérez-Garcia, José Manuel, La Verde, Nicla, Orcutt, James M., Cazzaniga, Marina E., Piette, Fanny, Antolín, Silvia, Aguirre, Elena, Cortes, Javier, Llombart-Cussac, Antonio, Di Cosimo, Serena, Kim, Rim S., Feng, Huichen, Lipchik, Corey, Lucas, Peter C., Srinivasan, Ashok, Wang, Ying, Song, Nan, Gavin, Patrick G., Balousek, April D., Paik, Soonmyung, Allegra, Carmen J., Wolmark, Norman, Pogue-Geile, Katherine L.
Published in Breast Cancer Res (2020)

Corrigendum: Natural History of Non-Small-Cell Lung Cancer with Bone Metastases

by Santini, Daniele, Barni, Sandro, Intagliata, Salvatore, Falcone, Alfredo, Ferraù, Francesco, Galetta, Domenico, Moscetti, Luca, La Verde, Nicla, Ibrahim, Toni, Petrelli, Fausto, Vasile, Enrico, Ginocchi, Laura, Ottaviani, Davide, Longo, Flavia, Ortega, Cinzia, Russo, Antonio, Badalamenti, Giuseppe, Collovà, Elena, Lanzetta, Gaetano, Mansueto, Giovanni, Adamo, Vincenzo, De Marinis, Filippo, Satolli, Maria Antonietta, Cantile, Flavia, Mancuso, Andrea, Tanca, Francesca Maria, Addeo, Raffaele, Russano, Marco, Sterpi, Michelle, Pantano, Francesco, Vincenzi, Bruno, Tonini, Giuseppe
Published in Sci Rep (2016)

Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort...

by Di Cosimo, Serena, Tagliaferri, Barbara, Generali, Daniele, Giudici, Fabiola, Agustoni, Francesco, Bernardo, Antonio, Borgonovo, Karen, Farina, Gabriella, Luchena, Giovanna, Luciani, Andrea, Nolè, Franco, Palmeri, Laura, Pietrantonio, Filippo, Poggi, Guido, Zucali, Paolo Andrea, Balletti, Emanuela, Catania, Giovanna, Bernocchi, Ottavia, D’Antonio, Federica, Giordano, Monica, Grossi, Francesco, Lasagna, Angioletta, La Verde, Nicla, Manzoni, Mariangela, Montagna, Benedetta, Olgiati, Angelo, Raimondi, Alessandra, Rampinelli, Irene, Verri, Elena, Zaniboni, Alberto, Di Maio, Massimo, Beretta, Giordano, Danova, Marco
Published in Cancers (Basel) (2021)

Correction 2: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study

by Cazzaniga, Marina, Verusio, Claudio, Ciccarese, Mariangela, Fumagalli, Alberto, Sartori, Donata, Valerio, Maria Rosaria, Airoldi, Mario, Moretti, Gabriella, Ficorella, Corrado, Arcangeli, Valentina, Diodati, Lucrezia, Zambelli, Alberto, Febbraro, Antonio, Generali, Daniele, Pistelli, Mirco, Garrone, Ornella, Musolino, Antonino, Vici, Patrizia, Maur, Michela, Mentuccia, Lucia, La Verde, Nicla, Bianchi, Giulia, Artale, Salvatore, Blasi, Livio, Piezzo, Michela, Atzori, Francesco, Turletti, Anna, Benedetto, Chiara, Cursano, Maria Concetta, Fabi, Alessandra, Gebbia, Vittorio, Schirone, Alessio, Palumbo, Raffaella, Ferzi, Antonella, Frassoldati, Antonio, Scavelli, Claudio, Clivio, Luca, Torri, Valter
Published in Oncotarget (2018)

Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study

by Cazzaniga, Marina, Verusio, Claudio, Ciccarese, Mariangela, Fumagalli, Alberto, Sartori, Donata, Ancona, Cristina, Airoldi, Mario, Moretti, Gabriella, Ficorella, Corrado, Arcangeli, Valentina, Diodati, Lucrezia, Zambelli, Alberto, Febbraro, Antonio, Generali, Daniele, Pistelli, Mirco, Garrone, Ornella, Musolino, Antonino, Vici, Patrizia, Maur, Michela, Mentuccia, Lucia, La Verde, Nicla, Bianchi, Giulia, Artale, Salvatore, Blasi, Livio, Piezzo, Matilde, Atzori, Francesco, Turletti, Anna, Benedetto, Chiara, Cursano, Maria Concetta, Fabi, Alessandra, Gebbia, Vittorio, Schirone, Antonio, Palumbo, Raffaella, Ferzi, Antonella, Frassoldati, Antonio, Scavelli, Claudio, Clivio, Luca, Torri on behalf of The EVA Study Group, Valter
Published in Oncotarget (2018)

Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study

by Cazzaniga, Marina, Verusio, Claudio, Ciccarese, Mariangela, Fumagalli, Alberto, Sartori, Donata, Valerio, Maria Rosaria, Airoldi, Mario, Moretti, Gabriella, Ficorella, Corrado, Arcangeli, Valentina, Diodati, Lucrezia, Zambelli, Alberto, Febbraro, Antonio, Generali, Daniele, Pistelli, Mirco, Garrone, Ornella, Musolino, Antonino, Vici, Patrizia, Maur, Michela, Mentuccia, Lucia, La Verde, Nicla, Bianchi, Giulia, Artale, Salvatore, Blasi, Livio, Piezzo, Matilde, Atzori, Francesco, Turletti, Anna, Benedetto, Chiara, Cursano, Maria Concetta, Fabi, Alessandra, Gebbia, Vittorio, Schirone, Alessio, Palumbo, Raffaella, Ferzi, Antonella, Frassoldati, Antonio, Scavelli, Claudio, Clivio, Luca, Torri on behalf of The EVA Study Group, Valter
Published in Oncotarget (2018)